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Background
The increasing demand for production of new recom-
binant pharmaceutical proteins constantly challenges our
efforts to improve existing production systems or to
develop new systems. So far the most commonly used
expression systems are based on the prokaryotic E. coli,
which is easy to grow and easy to manipulate, or mamma-
lian cells which are able to produce complex heterologous
proteins. However, these as well as other expression sys-
tems have drawbacks and do not express all proteins effi-
ciently, which emphasizes the need for development of
alternative systems.
Bioneer has developed an alternative recombinant pro-
tein expression system, the P170 Expression System [1],
which is based on the Gram positive lactic acid bacteria,
Lactococcus lactis. This host organism has GRAS status due
to its long term use in the dairy industry, and proteins pro-
duced in the system have already entered clinical trials.
The P170 Expression System is induced when a certain
threshold of lactate is reached in the culture. This type of
auto-induction eliminates the addition of exogenous
components to induce gene expression. Furthermore, the
protein of interest is fused to a secretion signal facilitating
secretion of the gene product into the culture supernatant.
The extracellular destination of the protein product
reduces the number of steps needed for the subsequent
downstream processing, thus helping to reduce the overall
cost of the process. Finally, we have composed a fermen-
tation medium devoid of animal derived components
which is a strict demand for production of pharmaceutical
proteins.
Despite all of these advantages, the production of lactic
acid – the primary end product of glucose metabolism –
will have a limiting effect on biomass production in L. lac-
tis. Lactic acid inhibits growth even when the acid is neu-
tralized by addition of base to keep pH constant. As a
consequence the yield in biomass production is below
that of other expression systems with cell densities of
approximately 20 OD600 units. With this limited cell den-
sity we have still been able to produce up to 200–300 mg/
L of secreted protein, but although this level is acceptable
for some high value proteins, in most cases higher produc-
tion levels are desirable.
JURAG has developed the "Reverse Electro Enhanced
Dialysis (REED)" process which is a membrane filtration
technology that allows continuous removal of low-molec-
ular weight negative ions like lactate from the fermenta-
tion broth [2]. The lactic acid produced by the lactic acid
bacteria dissociate in the growth medium to form lactate,
which is replaced by alkaline hydroxide ions during the
REED separation process. In this way both pH and lactate
content in the culture are kept constant. By applying this
technology the exponential growth phase could be pro-
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longed resulting in a substantial increase in the final bio-
mass yield. The effect of the REED unit was demonstrated
by an increase in the biomass yield by more than 10-fold
when compared to a standard fermentation.
Results
Here we describe the synergistic effects of the REED tech-
nology in combination with the P170 Expression System
for increased production and secretion of the model pro-
tein Staphylococcus aureus nuclease (SNase). In the first
phase of the fermentation the REED unit was used to con-
trol the lactate concentration below 150 mM to sustain
rapid exponential growth until the optical density reached
70 OD600 units. The lactate concentration was then
increased to 250 mM and kept between 250 and 350 mM
for 21 hours. Growth continued at a decreasing rate, while
a high specific productivity of SNase was obtained. The
culture was continuously fed with concentrated medium,
while superfluous volume was drained from the fermen-
tor to keep a constant volume. The figure below shows the
yield of biomass and the yield of SNase obtained during
the REED fermentation. As can be seen in figure 1 the cell
density reached 180 OD600 units while the concentration
of secreted SNase exceeded 2 g/L, which is approximately
10 fold higher compared to a standard fermentation with-
out lactate control.
Conclusion
The present data demonstrates the enormous potential for
increasing the yields of recombinant proteins produced in
L. lactis by combining the advantages of the P170 Expres-
sion System for production of recombinant proteins with
the power of the REED separation technology for improv-
ing yields. Two other commercially relevant proteins have
also been tested in the combined system and 5–10 fold
increased production levels were demonstrated.
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Cell density and yield of secreted heterologous protein (SNas ) during continuous fermenta ion with pH controlled by REED, compared t  th  ba ch fermentati n wher  pH was co trolled b  titration with KOH s uFigur  1
Cell density and yield of secreted heterologous protein 
(SNase) during continuous fermentation with pH controlled 
by REED, compared to the batch fermentation where pH 































OD in REED fermentation
OD in batch fermentation
mg/L SNase in REED fermentation
mg/mL SNase in batch fermentationPage 2 of 2
(page number not for citation purposes)
